Search Results - "Kanniess, F"

Refine Results
  1. 1

    Roflumilast for asthma: Efficacy findings in mechanism of action studies by Bardin, P, Kanniess, F, Gauvreau, G, Bredenbröker, D, Rabe, K.F

    Published in Pulmonary pharmacology & therapeutics (01-12-2015)
    “…Abstract Background The efficacy profile of roflumilast, a phosphodiesterase-4 inhibitor used for the treatment of chronic obstructive pulmonary disease…”
    Get full text
    Journal Article
  2. 2

    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler – Results from a non-interventional study by Schmidt, O., Petro, W., Hoheisel, G., Kanniess, F., Oepen, P., Langer-Brauburger, B.

    Published in Respiratory medicine (01-10-2017)
    “…Prospective, non-interventional study of fixed-dose inhaled corticosteroid (ICS)/long-acting beta2-agonist (LABA) combination therapy with fluticasone…”
    Get full text
    Journal Article
  3. 3

    Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial by Judson, M. A, Baughman, R. P, Costabel, U, Flavin, S, Lo, K. H, Kavuru, M. S, Drent, M, Centocor T48 Sarcoidosis investigators

    Published in The European respiratory journal (01-06-2008)
    “…The aim of the present study was to investigate the efficacy of infliximab for the treatment of extrapulmonary sarcoidosis. A prospective, randomised,…”
    Get full text
    Journal Article
  4. 4

    The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma by Abraham, B, Antó, JM, Barreiro, E, Bel, EHD, Bonsignore, G, Bousquet, J, Castellsague, J, Chanez, P, Cibella, F, Cuttitta, G

    Published in The European respiratory journal (01-09-2003)
    “…Since severe asthma is a poorly understood, major health problem, 12 clinical specialist centres in nine European countries formed a European Network For…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Efficacy of Disease Management Programs Asthma and COPD? Results of a Cross-Sectional Study by Kanniess, F, Krockenberger, K, Oepen, P, Hedrich, R, Olbrich, D, Hessler, N, Ziegler, A, Langer-Brauburger, B

    Published in Pneumologie (Stuttgart, Germany) (01-03-2020)
    “…The efficacy of the German disease management programs (DMP) asthma and chronic obstructive pulmonary disease (COPD) cannot be shown with the legally bound…”
    Get more information
    Journal Article
  7. 7

    Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma by Kanniess, F, Richter, K, Bohme, S, Jorres, R.A, Magnussen, H

    Published in The European respiratory journal (01-10-2002)
    “…Whether leukotriene receptor antagonists exhibit adequate anti-inflammatory effects in the treatment of asthma is still a controversial issue. The aim of the…”
    Get full text
    Journal Article
  8. 8

    Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients by Joos, G.F, Schelfhout, V.J, Pauwels, R.A, Kanniess, F, Magnussen, H, Lamarca, R, Jansat, J.M, Garcia Gil, E

    Published in Respiratory medicine (01-06-2010)
    “…Summary Background Aclidinium bromide is a novel, long-acting, inhaled muscarinic antagonist bronchodilator currently in Phase III clinical development for the…”
    Get full text
    Journal Article
  9. 9

    The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease by Grönke, L., Kanniess, F., Holz, O., Jörres, R. A., Magnussen, H.

    Published in Clinical and experimental allergy (01-01-2002)
    “…Background The combination of airway hyper‐responsiveness, eosinophilic airway inflammation, and lung function impairment is considered as a hallmark of…”
    Get full text
    Journal Article
  10. 10

    Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering by van den Berge, M, Arshad, S.H, Ind, P.W, Magnussen, H, Hamelmann, E, Kanniess, F, Postma, D.S

    Published in Respiratory medicine (01-08-2009)
    “…Summary Rationale Oral corticosteroids effectively treat asthma exacerbations but are associated with well-described side effects. Objective This study…”
    Get full text
    Journal Article
  11. 11

    In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation by LOPPOW, D, SCHLEISS, M.B, KANNIESS, F, TAUBE, C, JÖRRES, R.A, MAGNUSSEN, H

    Published in Respiratory medicine (01-02-2001)
    “…Systemic corticosteroids have been recommended as a therapeutic option in patients with moderate to severe COPD. In an early stage of the disease, i.e. chronic…”
    Get full text
    Journal Article
  12. 12

    Effect of Inhaled Ciclesonide on Airway Responsiveness to Inhaled AMP, the Composition of Induced Sputum and Exhaled Nitric Oxide in Patients with Mild Asthma by Kanniess, F., Richter, K., Böhme, S., Jörres, R.A., Magnussen, H.

    Published in Pulmonary pharmacology & therapeutics (01-01-2001)
    “…To assess the efficacy of ciclesonide, a novel corticosteroid pro-drug, we compared its effect on lung function, airway responsiveness to inhaled AMP, the…”
    Get full text
    Journal Article
  13. 13

    Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD by Zuhlke, I.E, Kanniess, F, Richter, K, Nielsen-Gode, D, Bohme, S, Jorres, R.A, Magnussen, H

    Published in The European respiratory journal (01-12-2003)
    “…This study assessed the effect of the leukotriene receptor antagonist montelukast on hypertonic saline-induced airway obstruction. A total of 29 patients with…”
    Get full text
    Journal Article
  14. 14

    Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma by Kanniess, F, Richter, K, Janicki, S, Schleiss, M.B, Jorres, R.A, Magnussen, H

    Published in The European respiratory journal (01-11-2002)
    “…The present study aimed at comparing the effects of a dose reduction of inhaled corticosteroids on lung function, indirect measures of airway inflammation and…”
    Get full text
    Journal Article
  15. 15

    Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma by TAUBE, C, KANNIESS, F, GRÖNKE, L, RICHTER, K, MÜCKE, M, PAASCH, K, EICHLER, G, JÖRRES, R.A, MAGNUSSEN, H

    Published in Respiratory medicine (01-05-2003)
    “…The aim of the present study was to assess the reproducibility of changes in forced inspiratory volumes after bronchodilator inhalation. Thirteen patients with…”
    Get full text
    Journal Article
  16. 16

    Assessment of accuracy and applicability of a new electronic peak flow meter and asthma monitor by Richter, K, Kanniess, F, Mark, B, Jorres, RA, Magnussen, H

    Published in The European respiratory journal (01-08-1998)
    “…The aim of this study was to assess the accuracy and applicability of a portable electronic peak flow meter combined with an asthma monitor (AM1, Jaeger,…”
    Get full text
    Journal Article
  17. 17

    Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosols by Holz, O, Zühlke, I, Einhaus, M, Welker, L, Kanniess, F, Branscheid, D, Nakashima, M, Harrison, L.I, Jörres, R.A, Richter, K, Magnussen, H

    Published in Pulmonary pharmacology & therapeutics (01-01-2004)
    “…Indirect assessments have shown a superior lung deposition of HFA–BDP (Ventolair ®/Qvar ®) compared to CFC–BDP (Aerobec ®). The aim of this study was to assess…”
    Get full text
    Journal Article
  18. 18

    Combined inhalation of nitric oxide and oxygen in patients with moderate to severe COPD: effect on blood gases by KANNIESS, F, JÖRRES, R.A, MAGNUSSEN, H

    Published in Respiratory medicine (01-12-2001)
    “…Inhaled nitric oxide (NO) has been reported to improve oxygenation in patients with COPD if administered in combination with oxygen (O2). Little, however, is…”
    Get full text
    Journal Article
  19. 19
  20. 20